Sanofi taps Alloy Therapeutics for CNS antisense drug development – Pharmaceutical Technology
The companies have teamed up to use Alloy’s AntiClastic Antisense platform. Credit: Bevan Goldswain via Getty Images. Sanofi has entered into a collaboration and license